Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10958-10962

  Tran, Erin E H ^a   Simmons, James A ^b   Bartesaghi, Alberto ^a   Shoemaker, Charles J ^b   Nelson, Elizabeth ^b   White, Judith M ^b   Subramaniam, Sriram ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; VIRUS ENVELOPE PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; EBOLA VIRUS; ELECTRON TOMOGRAPHY; MUCIN LIKE DOMAIN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; VIRUS PARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CRYOELECTRON MICROSCOPY; EBOLA HEMORRHAGIC FEVER; GENETICS; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; ULTRASTRUCTURE; VIROLOGY;

CRYOELECTRON MICROSCOPY; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; VIRAL ENVELOPE PROTEINS;

EID: 84906346444     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00870-14     Document Type: Article

References (25)

1. Hartman AL, Towner JS, Nichol ST. 2010. Ebola and Marburg hemorrhagic fever. Clin. Lab Med. 30:161-177. http://dx.doi.org/10.1016/j.cll .2009.12.001.
2. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
3. Lee JE, Saphire EO. 2009. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 4:621- 635. http://dx.doi.org/10 .2217/fvl.09.56.
4. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43:189-219. http://dx.doi .org/10.1080/10409230802058320.
5. Lee JE, Saphire EO. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182. http: //dx.doi.org/10.1038/nature07082.
6. Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, Kobinger GP. 2012. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4:138ra81. http://dx.doi.org/10.1126 /scitranslmed.3003876.
7. Olinger GG, Jr., Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. 2012. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 109: 18030-18035. http://dx.doi.org/10.1073/pnas.1213709109.
8. Kaletsky RL, Simmons G, Bates P. 2007. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J. Virol. 81:13378- 13384. http://dx.doi.org/10.1128/JVI.01170-07.
9. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178. http://dx.doi.org/10.1128/JVI.80.8 .4174-4178.2006.
10. Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. 2014. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. mBio 5:e00862-13. http://dx.doi.org/10.1128/mBio.00862-13.
11. Marzi A Möller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, Becker S, Baribaud F, Pöhlmann S. 2007. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DCSIGNR. J. Infect. Dis. 196(Suppl 2):S237-S246. http://dx.doi.org/10.1086 /520607.
12. Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T, Feldmann H, Takada A. 2010. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem. Biophys. Res. Commun. 403:144-148. http://dx.doi.org/10.1016/j.bbrc.2010.10.136.
13. Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK. 2000. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287:1664-1666. http://dx.doi.org/10.1126/science .287.5458.1664.
14. Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. 2009. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J. Virol. 83:9596-9601. http: //dx.doi.org/10.1128/JVI.00784-09.
15. Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P. 2010. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathog. 6:e1001098. http://dx.doi.org/10.1371/journal.ppat.1001098.
16. Martinez O, Tantral L, Mulherkar N, Chandran K, Basler CF. 2011. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. J. Infect. Dis. 204(Suppl 3):S825-S832. http://dx.doi.org/10.1093/infdis/jir295.
17. Dowling W, Thompson E, Badger C, Mellquist JL, Garrison AR, Smith JM, Paragas J, Hogan RJ, Schmaljohn C. 2007. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of Ebola virus GP DNA vaccines. J. Virol. 81:1821-1837. http://dx.doi.org/10.1128 /JVI.02098-06.
18. Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM. 2013. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS One 8:e56265. http://dx.doi.org/10.1371 /journal.pone.0056265.
19. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S. 2012. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog. 8:e1002797. http://dx.doi.org/10.1371/journal.ppat.1002797.
20. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S. 2010. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog. 6:e1001249. http://dx.doi.org/10.1371 /journal.ppat.1001249.
21. Beniac DR, Melito PL, Devarennes SL, Hiebert SL, Rabb MJ, Lamboo LL, Jones SM, Booth TF. 2012. The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy. PLoS One 7:e29608. http://dx .doi.org/10.1371/journal.pone.0029608.
22. Olal D, Kuehne AI, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Jr, Saphire EO. 2012. Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus. J. Virol. 86:2809-2816. http://dx.doi.org/10.1128 /JVI.05549-11.
23. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31:1947-1960. http://dx.doi.org/10.1038 /emboj.2012.53.
24. Dube D, Brecher MB, Delos SE, Rose SC, Park EW, Schornberg KL, Kuhn JH, White JM. 2009. The primed ebolavirus glycoprotein (19- kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 83:2883-2891. http://dx.doi.org/10.1128/JVI.01956-08.
25. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612. http: //dx.doi.org/10.1002/jcc.20084.